June 17th, 2010 - 08:41 GMT Merck Serono Resumes Stimuvax Clinical Program in Lung Cancer • FDA lifts clinical hold on START clinical trial Read more
April 6th, 2010 - 09:30 GMT Merck Serono: Erbitux granted extended use in Japan for 1st-line treatment of mCRC Patients with KRAS wild-type tumors
